Top 5 United States Durable Medical Equipment Companies
Masimo
Medtronic
Pride Mobility Products
Nihon Kohden
Koninklijke Philips
Source: Mordor Intelligence
United States Durable Medical Equipment Companies Matrix by Mordor Intelligence
Our comprehensive proprietary performance metrics of key United States Durable Medical Equipment players beyond traditional revenue and ranking measures
The top company list can diverge from this MI Matrix because scale alone does not guarantee steady delivery, strong uptime, or fast remediation. Several firms score better here because they show clear post 2023 signals like FDA clearances, measurable rollout activity, or sharper product refresh cadence. In US durable medical equipment, buyers often ask what qualifies for Medicare coverage and what supplier rules apply during audits. CMS DMEPOS quality standards and Medicare bidding rules shape how devices get delivered, trained, and serviced in the home. Capability indicators that shift scores include recall remediation discipline, software interoperability with hospital systems, US based production or service footprints, and evidence of connected monitoring adoption. This MI Matrix by Mordor Intelligence is better for supplier and competitor evaluation than revenue tables alone because it weights practical delivery and product progress.
MI Competitive Matrix for United States Durable Medical Equipment
The MI Matrix benchmarks top United States Durable Medical Equipment Companies on dual axes of Impact and Execution Scale.
Analysis of United States Durable Medical Equipment Companies and Quadrants in the MI Competitive Matrix
Comprehensive positioning breakdown
Koninklijke Philips NV
Systemwide standardizations can reshape buyer behavior more than single product wins. Philips, a major player in patient monitoring, announced a 10 year collaboration with Hoag in October 2025 to standardize and modernize monitoring across two acute care hospitals. This kind of footprint supports training consistency and refresh cycles for vital sign monitoring categories. Medicare payment pressure and supplier accreditation expectations still raise the bar for uptime and documentation. If implementation runs smoothly, Philips can expand within similar regional systems. The risk is execution drag from complex rollouts.
Medtronic PLC
Interoperability is becoming a buyer requirement, not a bonus feature. Medtronic, a leading company across therapeutic devices, said in April 2025 it submitted 510(k) applications seeking clearance for an interoperable insulin pump and a compatible algorithm approach tied to an Abbott CGM integration path. In December 2025, Reuters reported that its MiniMed diabetes business filed for a US IPO, signaling a sharper operating focus for that portfolio. If separation accelerates product cadence, Medtronic can gain. The risk is distraction during separation and regulatory follow through.
Pride Mobility
Travel focused designs often show up first in mobility innovation. Pride Mobility, a top manufacturer in power mobility, launched three travel power wheelchairs in December 2025, including models built around carbon fiber frames and different weight capacities. Pride also promoted the Jazzy Ultra Light launch in late 2024, reinforcing the portability direction. Medicare coding and documentation still affect how widely power chairs are prescribed versus cash purchased. If travel mobility demand keeps rising, Pride can expand channel pull. The risk is battery and service support complexity at scale.
Frequently Asked Questions
What should hospitals verify before standardizing vital sign monitors or infusion pumps?
Confirm FDA status, software update process, cybersecurity controls, and alarm performance history. Ask for evidence of field remediation speed and training coverage.
How do Medicare DMEPOS quality standards change home delivery expectations?
They raise requirements for intake, setup, patient training, and follow up. Strong suppliers document each step, which reduces claim denials and audit risk.
What features matter most when selecting home oxygen equipment?
Focus on reliability, alarms, battery runtime, noise level, and service response time. Also confirm availability of replacement parts and clear patient instructions.
How should buyers evaluate travel power wheelchairs for broader adoption?
Look at total carry weight, fold method, battery handling rules, and repair turnaround time. Real world durability and parts availability usually matter more than top speed.
What are common operational risks for US durable medical equipment suppliers through 2030?
Recall related disruption, component shortages, and staffing gaps in repair networks are persistent risks. Reimbursement pressure can also shift product mix toward lower service models.
How can providers reduce exposure to recalls and software issues?
Require a written remediation plan, upgrade timelines, and clear communication protocols. Track serial numbers and maintenance history so affected devices can be identified quickly.
Methodology
Research approach and analytical framework
We prioritized company investor relations, SEC filings, FDA notices, and official press rooms. We used reputable journalism and trade publications for observable contracts, expansions, and launches. Private firm scoring relied on facilities, product releases, and distribution signals. When financial detail was limited, we triangulated using operational and regulatory evidence.
US service coverage and channel reach determine delivery speed for beds, mobility devices, and monitoring equipment.
Clinician and HME trust affects standardization decisions for vital sign monitors, infusion pumps, and mobility lines.
Relative adoption proxies such as installed base and contract visibility signal where buyers already commit budgets.
US production, repair capacity, and field service depth drive uptime for large assets like beds and pumps.
FDA cleared updates, connectivity, and lighter mobility designs influence discharge pathways and home monitoring use.
Financial resilience supports recalls, software updates, and inventory during reimbursement and demand swings.
